TPTX NASDAQ
Turning Point Therapeutics, Inc.
1W: +1.3%
1M: +1.6%
3M: +134.0%
1Y: +13.9%
3Y: +79.2%
$75.49
Last traded 2022-08-16 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
📊 Key Metrics
TTM$1M
Revenue
-98.1% YoY
$-342M
Net Income
-118.2% YoY
$-263M
Free Cash Flow
-188.6% YoY
100.0%
Gross Margin
-103435.3%
Op. Margin
-103435.3%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-36.8%
ROA-35.2%
ROIC1331.6%
Valuation
P/E-13.0
P/B3.2
EV/EBITDA-8.7
Leverage
Debt/Equity0.01
Current Ratio16.83
Interest Cov.0.0x
Quality Scores
Piotroski F2/9
Altman Z43.19
Beneish M-20.00